Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Hematologic
Hematologic
This is a Phase 2, randomized, multicenter study to evaluate the efficacy and safety of KD025 in subjects with Chronic Graft Versus Host Disease (cGVHD) after at least 2 prior lines of systemic therapy
Hematologic
II
Kitko, Carrie
NCT03640481
VICCCTT18121
